PECAM1 and colorectal carcinoma: We have studied the relationship between CSE1L expression and tumor cell lymphatic vessel invasion and blood vessel invasion, using 60 whole-mount sections of CRC specimens with antibodies against the D2-40 lymphatic endothelial marker and the CD31 blood vessel endothelial marker.